These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19540689)

  • 41. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.
    Jan W; Zimmerman RA; Wang ZJ; Berry GT; Kaplan PB; Kaye EM
    Neuroradiology; 2003 Jun; 45(6):393-9. PubMed ID: 12736767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Age-dependent changes in metabolites of the normal brain in childhood : observation by proton MR spectroscopy].
    Tanouchi M; Harada M; Hashimoto T; Nishitani H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 May; 56(6):405-10. PubMed ID: 8710464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diffusion-weighted MR imaging and MR spectroscopy in glutaric aciduria type 1.
    Oguz KK; Ozturk A; Cila A
    Neuroradiology; 2005 Mar; 47(3):229-34. PubMed ID: 15776225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined MR measurements of magnetization transfer, tissue diffusion and proton spectroscopy. A feasibility study with neurological cases.
    Back T; Möckel R; Hirsch JG; Gaa J; Oertel WH; Hennerici MG; Gass A
    Neurol Res; 2003 Apr; 25(3):292-300. PubMed ID: 12739241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Age-related metabolic changes in the corpus callosum: assessment with MR spectroscopy.
    Bozgeyik Z; Burakgazi G; Sen Y; Oğur E
    Diagn Interv Radiol; 2008 Dec; 14(4):173-6. PubMed ID: 19061159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proton MR spectroscopy in patients with pyogenic brain abscess: MR spectroscopic imaging versus single-voxel spectroscopy.
    Hsu SH; Chou MC; Ko CW; Hsu SS; Lin HS; Fu JH; Wang PC; Pan HB; Lai PH
    Eur J Radiol; 2013 Aug; 82(8):1299-307. PubMed ID: 23453705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffusion magnetic resonance imaging patterns in metabolic and toxic brain disorders.
    Sener RN
    Acta Radiol; 2004 Aug; 45(5):561-70. PubMed ID: 15515520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI.
    Janson CG; McPhee SW; Francis J; Shera D; Assadi M; Freese A; Hurh P; Haselgrove J; Wang DJ; Bilaniuk L; Leone P
    Neuropediatrics; 2006 Aug; 37(4):209-21. PubMed ID: 17177147
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rasmussen's encephalitis: proton MR spectroscopy and diffusion MR findings.
    Sener RN
    J Neuroradiol; 2000 Sep; 27(3):179-84. PubMed ID: 11104965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted MR imaging and proton MR spectroscopy of the brain.
    Razek AA; Abdalla A; Ezzat A; Megahed A; Barakat T
    Neuroradiology; 2014 Oct; 56(10):885-91. PubMed ID: 25060166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. L-2 hydroxyglutaric aciduria: proton magnetic resonance spectroscopy and diffusion magnetic resonance imaging findings.
    Sener RN
    J Comput Assist Tomogr; 2003; 27(1):38-43. PubMed ID: 12544241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neonatal hypoglycaemic encephalopathy: diffusion-weighted imaging and proton MR spectroscopy.
    Kim SY; Goo HW; Lim KH; Kim ST; Kim KS
    Pediatr Radiol; 2006 Feb; 36(2):144-8. PubMed ID: 16284763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MR spectroscopy of intracranial tuberculomas: A singlet peak at 3.8 ppm as potential marker to differentiate them from malignant tumors.
    Morales H; Alfaro D; Martinot C; Fayed N; Gaskill-Shipley M
    Neuroradiol J; 2015 Jun; 28(3):294-302. PubMed ID: 26246099
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Can proton magnetic resonance spectroscopy be of any value as a prognostic factor in medulloblastoma?].
    Dembowska-Bagińska B; Perek D; Perek-Polnik M; Drogosiewicz M; Jurkiewicz E; Pakuła-Kościesza I; Grajkowska W; Roszkowski M
    Med Wieku Rozwoj; 2003; 7(2):229-39. PubMed ID: 12878794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic hypothermia for neonatal encephalopathy results in improved microstructure and metabolism in the deep gray nuclei.
    Bonifacio SL; Saporta A; Glass HC; Lee P; Glidden DV; Ferriero DM; Barkovich AJ; Xu D
    AJNR Am J Neuroradiol; 2012 Dec; 33(11):2050-5. PubMed ID: 22595900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MRS features during encephalopathic crisis period in 11 years old case with GA-1.
    Kurtcan S; Aksu B; Alkan A; Guler S; Iscan A
    Brain Dev; 2015 May; 37(5):546-51. PubMed ID: 25277297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Value of 1H-MRS and MRI in Combined Methylmalonic Aciduria and Homocystinuria.
    Cheng A; Yao R; Cao W; Yu H
    J Comput Assist Tomogr; 2019; 43(4):559-562. PubMed ID: 30839328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1H Magnetic resonance spectroscopy findings in idiopathic inflammatory myopathies at 3 T: feasibility and first results.
    Subhawong TK; Wang X; Machado AJ; Mammen AL; Christopher-Stine L; Barker PB; Carrino JA; Fayad LM
    Invest Radiol; 2013 Jul; 48(7):509-16. PubMed ID: 23563194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sequential evaluation of brain lesions using functional magnetic resonance imaging in patients with Leigh syndrome].
    Chen Z; Li J; Lou X; Ma L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Oct; 32(10):1474-7. PubMed ID: 23076188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [MRI in the diagnosis of congenital white matter diseases and other neurodegenerative diseases].
    Bekiesińska-Figatowska M; Walecki J; Wagiel K; Jurkiewicz E
    Neurol Neurochir Pol; 2001; 35(4):605-19. PubMed ID: 11783404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.